Your browser doesn't support javascript.
loading
Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article.
Yosaee, Somaye; Soltani, Sepideh; Sekhavati, Eghbal; Jazayeri, Shima.
Afiliación
  • Yosaee S; Dept. of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran; Ewaz School of Health, Larestan School of Medical Sciences, Larestan, Iran.
  • Soltani S; Dept. of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • Sekhavati E; Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Jazayeri S; Dept. of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran; Research Center for Prevention of Cardiovascular Disease, Iran University of Medical Sciences, Tehran, Iran.
Iran J Public Health ; 45(12): 1568-1576, 2016 Dec.
Article en En | MEDLINE | ID: mdl-28053922
BACKGROUND: Heart disease is one of the most common chronic disease and leading cause of morbidity and mortality worldwide. Adropin, a newly identified protein, is important for energy homeostasis and maintaining insulin sensitivity, and has been referred to as a novel regulator of endothelial cells. Endothelial dysfunction is a key early event in atherogenesis and onset of HD. Therefore, this review gives a systematic overview of studies investigating plasma adropin level in patient with heart disease. METHODS: Data carried out in PubMed, Scopus, Web of Science, Embase, Google scholar and MEDLINE, from the earliest available online indexing year through 2015. The search restricted to studies conducted in humans. The keyword search was adropin to apply in title, abstract and keywords. References lists of all original published articles were scanned to find additional eligible studies. RESULTS: Heart failure (HF), coronary atherosclerosis acute myocardial infarction and Cardiac Syndrome X (CSX) were type of heart disease acknowledged in this study. Majority of evidences introduced low adropin as an independent risk factor of heart disease. In a case-control study, the plasma level of adropin increased with the severity of HF. CONCLUSION: Adropinmay be a potential serum biomarker for early diagnosis of HD.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Idioma: En Revista: Iran J Public Health Año: 2016 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Idioma: En Revista: Iran J Public Health Año: 2016 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán